Intelligence Platform

Patents

Browse 650 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7816532

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7807164

Lyophilized VEGF antagonist formulations for intravitreal administration

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803560

Methods of screening for antagonists of mammalian monocyte chemoattractant protein recepto

The Regents of the University of California · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803812

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7799789

Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity

Pharmacopeia Drug Discovery, Inc. · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7795267

Bicyclic piperazine compound having TGR23 antagonistic activity

Takeda Pharmaceutical Company Limited · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7790728

Pyrazine derivatives useful as adenosine receptor antagonists

Laboratories Almirall, S.A. · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776879

Quinuclidine carbamate derivatives and their use as M3 antagonists

Almirall, S.A. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7759335

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders,

Jenrm Discovery, Inc. · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7754206

Method for treating cancer using a Notch4 ligand antagonist

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7731953

Methods for use of TSLP and agonists and antagonists thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7728144

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700547

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7691878

Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

Theravance, Inc. · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687521

Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor a

Theravance, Inc. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687481

Cannabinoid receptor antagonists/inverse agonists useful for treating obesity

Jenrin Discovery, LLC · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7687519

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Mar 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7683173

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7666889

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders,

Jenrin Discovery, LLC · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662365

Polymer conjugates of opioid antagonists

Nektar Therapeutics · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7659403

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655758

Stable liquid IL-1 antagonist formulations

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7655685

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders,

Jenrin Discovery, LLC · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7652035

CRF receptor antagonists and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted